The basketball community is holding its breath following the San Antonio Spurs’ announcement that Victor Wembanyama, their 21-year-old French phenom, has been sidelined by a rare deep vein thrombosis (DVT) in his right shoulder. Diagnosed after his return from the All-Star Game in San Francisco, Wembanyama’s blood clot has paused his breakout NBA season, which runs through mid-April. While it’s too soon to predict the full impact on his career, recent optimism from experts and peers like Shaquille O’Neal suggests a silver lining. As of February 24, 2025, this article explores the injury’s implications, treatment, and the Spurs’ shifting fortunes.
Understanding the Rare Condition
Victoria Tchaikovsky, a sports physician at Paris’ Drouot clinic, describes Wembanyama’s condition as “extremely rare” due to its shoulder location—unlike typical DVT cases in the legs. She attributes it to an “effort-induced blood clot,” likely triggered by the 7-foot-3 center’s intense physical regimen. The primary danger lies in the clot potentially migrating to the lungs, risking a pulmonary embolism. Treatment requires anticoagulants to dissolve the clot, but this bars him from contact sports, as even minor hits could cause severe bleeding or bruising. O’Neal, reflecting on his own towering frame, noted such issues are more common among tall athletes, praising the early catch.
Lessons from NBA Precedents
Wembanyama’s prognosis draws mixed parallels. Players like Ausar Thompson and Brandon Ingram overcame similar clots to resume their careers, offering hope. Yet, Chris Bosh’s story looms large—recurring clots in his lung and leg forced his retirement in 2017 at 32 after missing multiple seasons. Wembanyama’s single, early-detected clot leans toward a more positive outlook, with the Spurs eyeing his return next season. Charles Barkley called it a blow to the league, especially after the Spurs’ recent signing of De’Aaron Fox elevated their contender status.
Though Wembanyama’s blood clot halts his current campaign, the swift diagnosis fuels optimism for a full recovery by 2025-26. As of February 24, 2025, the Spurs and fans alike await his triumphant return, buoyed by medical advances and historical resilience.
